| SC 13G/A | 2017-02-14 | PERCEPTIVE ADVISORS LLC | Versartis, Inc. | 4,153,685 | 11.9% | EDGAR |
| SC 13G/A | 2017-02-14 | BAKER BROS. ADVISORS LP | Versartis, Inc. | 1,920,845 | 5.5% | EDGAR |
| SC 13G | 2017-02-10 | Advent Life Sciences LLP | Versartis, Inc. | 2,271,558 | 6.5% | EDGAR |
| SC 13G | 2017-02-08 | Index Ventures IV (Jersey) LP | Versartis, Inc. | 2,169,930 | 6.2% | EDGAR |
| SC 13D/A | 2017-02-07 | Sofinnova Venture Partners VIII, L.P. | Versartis, Inc. | 2,361,978 | 6.8% | EDGAR |
| SC 13G/A | 2017-02-03 | AISLING CAPITAL III LP | Versartis, Inc. | 2,524,465 | 7.3% | EDGAR |
| SC 13G | 2017-01-30 | BlackRock Inc. | Versartis, Inc. | 2,215,367 | 6.4% | EDGAR |
| SC 13G/A | 2016-12-09 | BAKER BROS. ADVISORS LP | Versartis, Inc. | 2,006,227 | 5.8% | EDGAR |
| SC 13D/A | 2016-11-14 | New Leaf Ventures II, L.P. | Versartis, Inc. | 2,039,223 | 5.9% | EDGAR |
| SC 13G/A | 2016-10-05 | PERCEPTIVE ADVISORS LLC | Versartis, Inc. | 4,028,685 | 13.6% | EDGAR |
| SC 13G | 2016-02-26 | Advent Life Sciences LLP | Versartis, Inc. | 2,271,558 | 7.7% | EDGAR |
| SC 13G/A | 2016-02-16 | BAKER BROS. ADVISORS LP | Versartis, Inc. | 3,241,783 | 11.0% | EDGAR |
| SC 13G | 2016-02-16 | PERCEPTIVE ADVISORS LLC | Versartis, Inc. | 2,299,454 | 7.8% | EDGAR |
| SC 13G/A | 2016-02-12 | FMR LLC | Versartis, Inc. | 4,404,036 | 15.0% | EDGAR |
| SC 13G/A | 2016-02-05 | AISLING CAPITAL III LP | Versartis, Inc. | 2,279,568 | 7.8% | EDGAR |
| SC 13D/A | 2015-04-14 | New Leaf Ventures II, L.P. | Versartis, Inc. | 2,039,223 | 7.0% | EDGAR |
| SC 13G/A | 2015-02-17 | RA CAPITAL MANAGEMENT, LLC | Versartis, Inc. | 231,267 | 1.0% | EDGAR |
| SC 13G | 2015-02-17 | Advent Life Sciences LLP | Versartis, Inc. | 2,216,558 | 9.1% | EDGAR |
| SC 13G | 2015-02-13 | Index Venture Associates IV Ltd | Versartis, Inc. | 2,169,930 | 7.6% | EDGAR |
| SC 13G | 2015-02-10 | BAKER BROS. ADVISORS LP | Versartis, Inc. | 2,977,396 | 10.2% | EDGAR |